Pathology
Blood Test May Predict Recurrence of Breast Cancer
The use of measuring circulating tumor cells (CTC) blood test in a new way has been explored. Currently, the test is FDA-approved for use by physicians to monitor response to treatment in patients with advanced breast, colon or prostate cancer, but not early stage cancer. More...19 Dec 2017
New Assay Predicts Cancerous Pancreatic Lesions
A new simple molecular test has been developed to detect chromosomal abnormalities, biomarkers known as telomere fusions, in pancreatic tumor specimens and pancreatic cyst fluids. This assay may help predict the presence of high-grade or invasive pancreatic cancers requiring surgical intervention. More...18 Dec 2017
Single Cell Genomics Utilized for Evaluation of Prostate Cancer
A distinction between indolent and aggressive disease is a major challenge in diagnostics of prostate cancer. Histopathology of tissue biopsies is a standard method used for evaluating cancer risk. Many decades of experience have led to classification of the histological types correlated with clinical outcome. More...13 Dec 2017
Oral Microbiome Composition Reflects Risk for Esophageal Cancers
Esophageal cancer is the eighth most common cancer and the sixth leading cause of cancer death worldwide. Because the disease is often not discovered until it has reached an advanced stage, five-year survival rates range from about 15% to 25% worldwide. More...12 Dec 2017
Prion Protein Found in Skin of CJD Patients
Creutzfeldt-Jakob disease (CJD) is an incurable, and ultimately fatal, transmissible, neurodegenerative disorder in the family of prion diseases. Prion diseases originate when normally harmless prion protein molecules become abnormal and gather in clusters and filaments in the human body and brain. More...07 Dec 2017
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Clinical Informatics Platform
CLARION™
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
In Other News
Simple Test Helps CF Patients Find Best Treatment
Diagnostic Test Identified for Pediatric Biliary Atresia
CSF Analyzed in Lung Cancer with Brain Metastases
Blood Test Reduces Interim for Evaluating Cancer Treatment
Low Testosterone Men Less Likely to Have Prostate Cancer
Immunoassay Quantifies Cancer Cell Loss During Treatment
Blood Test Detects Resistance to BRCA-Targeting Drugs
Esophageal Cancer in Relative Increases Barrett’s Risk
New Method Helps Rule Out Heart Valve Infection
Blood Test Can Effectively Rule Out Breast Cancer
Noninvasive Test Detects Bladder Cancer
CK-MB Assay Used to Diagnose Acute Myocardial Infarction
Single-Cell Diagnostics Advocated for Breast Cancer Subtyping
Urine-Based Markers for Bladder Cancer Reviewed
Genetic Testing Recommended for Children at Risk for Retinoblastoma
Risk for Colorectal Cancer Linked to Polyps and Adenomas
Liquid Biopsy for Retinoblastoma Discovered
Metabolomics Analysis Applied to Investigate MPS
New 3D App Provides More Accurate Cancer Diagnosis
Liquid Biopsy Test Outperforms Prostate Cancer PCA3 Test
Pre-Op Test Can Detect Some Pancreatic Cancers
Genetic Test Discovered for Predicting Cancer Recurrence
HPV Testing Detects More Precancerous Lesions
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
